The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.

Saudi Pharm J · 2023 · PMC10203981 · PMID 37256102

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

Likewise, the MV duration was shorter in the oseltamivir group at linear regression analysis; however, it did not reach statistical significance (beta coefficient: −0.27, 95% CI: [-0.55,0.02], P = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.